Heym, Kenneth M <br/><br/>
Nonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: a predominance of musculoskeletal pain.  [electronic resource] 

 -  Journal of pediatric hematology/oncology  Mar 2015 
 - e111-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-3678 
<br/><br/><label>Standard No.: </label>10.1097/MPH.0000000000000277  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--adverse effects<br/>Benzamides--adverse effects<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate<br/>Infant<br/>Infant, Newborn<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Musculoskeletal Pain--chemically induced<br/>Piperazines--adverse effects<br/>Prognosis<br/>Pyrimidines--adverse effects<br/>Retrospective Studies<br/>Young Adult